Calcium and Magnesium in Preventing Peripheral Neuropathy Caused by Ixabepilone in Patients With Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Neuropathy|Pain|Recurrent Breast Carcinoma|Stage IV Breast Cancer
Interventions: DRUG: Calcium Gluconate|DRUG: Magnesium Sulfate|OTHER: Placebo|OTHER: Quality-of-Life Assessment|OTHER: Questionnaire Administration|DRUG: Ixabepilone
Sponsor: Mayo Clinic
Collaborators: National Cancer Institute (NCI)